“EUROIMMUN”Anti-Glutamate receptor (type NMDA) IIFT EUROPattern
Taiwan·Risk Class 2·MD·EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG·Registered Nov 13, 2019 – Nov 13, 2024Expired- Analysis ID
- eab5cf45226450d37a968a4a2a6682cb
- License Form
- Ministry of Health Medical Device Import No. 032962
- Customs Code
- DHA05603296200
- Manufacturer
- EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
- Manufacturer Country
- Germany
- Authorized Representative
- EUROIMMUN (SOUTH EAST ASIA) PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- This product is used for in vitro qualitative or semi-quantitative detection of anti-glutamine receptor (NMDA type) antibody immunoglobulin IgG antibody in human serum, plasma or cerebrospinal fluid (CSF) samples. Used to assist in the diagnosis of neurological disorders (encephalitis).
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C5660 Multiple autologous antibody immunoassay system
- Import Information
- Imported from abroad
- Registration Date
- Nov 13, 2019
- Expiry Date
- Nov 13, 2024
Access comprehensive regulatory information for “EUROIMMUN”Anti-Glutamate receptor (type NMDA) IIFT EUROPattern in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number eab5cf45226450d37a968a4a2a6682cb and manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. The authorized representative in Taiwan is EUROIMMUN (SOUTH EAST ASIA) PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.